Insider · CIK 0001977969
Carrie D'Andrea
Files at GRCE (Grace Therapeutics, Inc.). First filing -, latest -.
Carrie D'Andrea files SEC Form 4 as officer at GRCE (Grace Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Carrie D'Andrea has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 14, 2025 | GRCE Grace Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +30,000 | $0.00 | $0 | 30,000 | Apr 16, 2025 |
Questions about Carrie D'Andrea
Answered from the filings on this page, as of the latest one.
Is Carrie D'Andrea buying or selling?
Carrie D'Andrea has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Carrie D'Andrea's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Carrie D'Andrea has 0.
Where does Carrie D'Andrea file Form 4?
Carrie D'Andrea has filed Form 4 at GRCE (Grace Therapeutics, Inc.) as VP Clinical Operations. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.